CYV — Ceryvyn Therapeutics Share News
0.000.00%
Last trade - 00:00- AU$15.05m
- -AU$14.97m
- AU$0.00m
Brief: Opthea Expands Leadership Team With The Appointment Of Timothy E. Morris As Chief Financial Officer
Brief: Opthea Says FY Reported Net Loss, Including Non-Cash Charges, Of Us$92.8 Million
Brief: Opthea Ltd Says Opthea Secured Up To US$170 Mln In Non-Dilutive Financing
Australia's Opthea faces worst day in more than a year on discounted placement
Brief: Opthea Ltd Says Offer Price For $90 Million Placement Is A$1.15 Per New Share
Brief: Opthea Ltd Seeks Trading Halt
Brief: Opthea Data For Opt-302 In Combination With Ranibizumab For Polypoidal Choroidal Vasculopathy (Pcv) Presented At Arvo 2022
U.S. STOCKS ON THE MOVE-Opthea Ltd, Carnival Corp, Tesla Inc
Opthea's U.S. shares jump as SVB initiates with 'outperform' rating
NASDAQ RESUMED AT 11:12 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 11:07 AM
Australia Stock Exchange release from OPTHEA : Change in substantial holding
Australia Stock Exchange release from OPTHEA : Change in substantial holding
Australia Stock Exchange release from OPTHEA : Change in substantial holding
Australia Stock Exchange release from OPTHEA : Notice of General Meeting and Proxy Form
Australia Stock Exchange release from OPTHEA : Change in substantial holding
Australia Stock Exchange release from OPTHEA : Change in substantial holding
Australia Stock Exchange release from OPTHEA : Opthea presents at Oppenheimer's 32nd Healthcare Conference
Australia Stock Exchange release from OPTHEA : Change in substantial holding